241 related articles for article (PubMed ID: 31729720)
1. ABO hemolytic disease of newborn : Does newborn's blood group a risk factor?
Bel Hadj I; Boukhris R; Khalsi F; Namouchi M; Bougmiza I; Tinsa F; Hamouda S; Boussetta K
Tunis Med; 2019 Mar; 97(3):455-460. PubMed ID: 31729720
[TBL] [Abstract][Full Text] [Related]
2. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
3. Revisiting ABO incompatibility as a risk factor for significant neonatal hyperbilirubinemia.
Khurana R; Batra P; Faridi M; Khan N
Trop Doct; 2019 Jul; 49(3):201-204. PubMed ID: 30943888
[TBL] [Abstract][Full Text] [Related]
4. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
Akgül S; Korkmaz A; Yiğit S; Yurdakök M
Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
[TBL] [Abstract][Full Text] [Related]
5. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
[TBL] [Abstract][Full Text] [Related]
6. Indication of Mild Hemolytic Reaction Among Preterm Infants With ABO Incompatibility.
Yogev-Lifshitz M; Leibovitch L; Schushan-Eisen I; Taran C; Strauss T; Maayan-Metzger A
Pediatr Blood Cancer; 2016 Jun; 63(6):1050-3. PubMed ID: 26841084
[TBL] [Abstract][Full Text] [Related]
7. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
Kalakheti BK; Singh R; Bhatta NK; Karki A; Baral N
Kathmandu Univ Med J (KUMJ); 2009; 7(25):11-5. PubMed ID: 19483446
[TBL] [Abstract][Full Text] [Related]
8. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program.
Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ
J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
Chen JY; Ling UP
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
[TBL] [Abstract][Full Text] [Related]
10. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
11. The value of transcutaneous method of bilirubin measurement in newborn population with the risk of ABO hemolytic disease.
Stoniene D; Buinauskiene J; Markūniene E
Medicina (Kaunas); 2009; 45(10):792-7. PubMed ID: 19996666
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for ABO hemolytic disease.
Levine DH; Meyer HB
Clin Pediatr (Phila); 1985 Jul; 24(7):391-4. PubMed ID: 3924461
[TBL] [Abstract][Full Text] [Related]
14. Absence of severe neonatal ABO hemolytic disease at Intermountain Healthcare. Why?
Baer VL; Hulse W; Bahr TM; Ilstrup SJ; Christensen RD
J Perinatol; 2020 Feb; 40(2):352-353. PubMed ID: 31796840
[No Abstract] [Full Text] [Related]
15. Unconjugated and conjugated bilirubin in plasma from patients with erythroblastosis and neonatal hyperbilirubinemia.
Winsnes A; Bratlid D
Acta Paediatr Scand; 1972 Jul; 61(4):405-12. PubMed ID: 4625253
[No Abstract] [Full Text] [Related]
16. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
[TBL] [Abstract][Full Text] [Related]
17. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
Senterre T; Minon JM; Rigo J
Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
[TBL] [Abstract][Full Text] [Related]
18. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
19. Influence of birth weight on the severity of hemolytic disease of the newborn due to ABO incompatibility.
Gupte SC; Kothari J; Bhatia HM
Indian Pediatr; 1975 Jun; 12(6):477-83. PubMed ID: 1237468
[No Abstract] [Full Text] [Related]
20. Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.
Metcalf RA; Khan J; Andrews J; Mayock D; Billimoria Z; Pagano MB
J Pediatr Hematol Oncol; 2019 Nov; 41(8):632-634. PubMed ID: 30044350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
